Profile
Gary T.
Shearman formerly worked at Woodbrook Group Holdings, Inc., as President, Chief Executive Officer & Director, Nereus Pharmaceuticals, Inc., as Chairman, HBM Advisors USA LLC, as Chairman, Artisan Pharma, Inc., as Executive Chairman, Merck & Co., Inc., as Director-International Regulatory Affairs in 1992, ChemoCentryx, Inc., as Director, Bellus Health (Innodia), Inc., as Director, Rhone-Poulenc Rorer, Inc., as Senior Vice President-Global Drug Development in 2000, HBM Healthcare Investments AG, as Investment Manager, HBM Biocapital Ltd., as Investment Manager, and Max-Planck Institute of Psychiatry, as Fellow.
Dr. Shearman received his graduate degree and doctorate degree from the University of Rhode Island and undergraduate degree from the University of Massachusetts.
Former positions of Gary T. Shearman
| Companies | Position | End |
|---|---|---|
Nereus Pharmaceuticals, Inc.
 Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Chairman | 2013-04-28 |
| WOODBROOK GROUP HOLDINGS INC. | President | 2008-06-04 |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Corporate Officer/Principal | 1999-12-31 |
| MERCK & CO., INC. | General Counsel | 1991-12-31 |
| Max-Planck Institute of Psychiatry | Corporate Officer/Principal | - |
Training of Gary T. Shearman
| University of Rhode Island | Doctorate Degree |
| University of Massachusetts | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| WOODBROOK GROUP HOLDINGS INC. | Finance |
| Private companies | 9 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
HBM Healthcare Investments AG
 HBM Healthcare Investments AG Investment ManagersFinance HBM Healthcare Investments AG is a listed investment company which invests worldwide, primarily focusing on Europe, Asia and North America, in private and public companies in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas. It aims to invest mainly in a form of equity, but also considers convertible bonds, debt securities and derivatives. The investment focus is on later stage companies, and participates in follow-on investment rounds, also acquiring majority stake in target companies. It invests also in other funds. | Finance |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Commercial Services |
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Health Technology |
HBM Advisors USA LLC
 HBM Advisors USA LLC Investment ManagersFinance Headquartered in Philadelphia, Pennsylvania, HBM Advisors USA LLC is the US investment consulting arm of HBM BioVentures AG which is headquartered in Switzerland | Finance |
HBM Biocapital Ltd.
 HBM Biocapital Ltd. Financial ConglomeratesFinance Part of HBM Partners AG, HBM Biocapital Ltd. is a Caymanian company that provides investment services. The company is based in George Town, Cayman Islands. | Finance |
Artisan Pharma, Inc.
 Artisan Pharma, Inc. Hospital/Nursing ManagementHealth Services Artisan Pharma, Inc. provides critical-care and hospital-based therapeutics to patients. The firm focuses on the clinical development of drugs in the field of critical care therapeutics throughout the world. The company was founded by Kazuhisa Tsuruta in 2006 and is headquartered in Waltham, MA. | Health Services |
| Max-Planck Institute of Psychiatry |
- Stock Market
- Insiders
- Gary T. Shearman
